May 13, 2017
Article
An essay honoring SARA SARGENTE, RN, OCN [ORANGE REGIONAL MEDICAL CENTER, MIDDLETOWN, NEW YORK]
Optune Plus Temodar and Keytruda May Result in Brain Tumor Control
ICI Response May Predict Relapse-Free Survival in Liver Cancer
Taking Time to ‘Smell the Roses’
Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma